ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,852.27
0.46%
Gold vs US Dollar
2,323.49
-0.09%
Brent Oil
83.44
-0.04%
Bitcoin
63,166.52
0.00%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Ab Science Sa (0Q77)

  7. Ab Science Sa (0Q77) News

Ab Science (0Q77)

Ab Science Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q77
DateTimeSourceHeadlineSymbolCompany
13/03/202411:58UK RegulatoryAB Science : De nouvelles recherches montrent que le masitinib limite les dommages neuronaux dans un modèle de maladie neurodégénérative d’origine neuroimmuneLSE:0Q77Ab Science Sa
13/03/202411:58UK RegulatoryAB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative diseaseLSE:0Q77Ab Science Sa
07/03/202414:20UK RegulatoryAB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science developmentLSE:0Q77Ab Science Sa
07/03/202414:20UK RegulatoryAB Science propose un résumé de la conférence virtuelle qui s’est tenue le 4 mars 2024, avec pour objectif de faire le point sur le développement d'AB ScienceLSE:0Q77Ab Science Sa
06/03/202419:21UK RegulatoryAB Science annonce l’initiation de la couverture de son titre par deux sociétés d’analyse financières, DNA Finance d’une part, et par In Extenso Finance d’autre partLSE:0Q77Ab Science Sa
06/03/202419:21UK RegulatoryAB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the CompanyLSE:0Q77Ab Science Sa
01/03/202417:07UK RegulatoryAB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30LSE:0Q77Ab Science Sa
01/03/202417:07UK RegulatoryAB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CETLSE:0Q77Ab Science Sa
29/02/202410:49UK RegulatoryAB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CETLSE:0Q77Ab Science Sa
29/02/202410:49UK RegulatoryAB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30LSE:0Q77Ab Science Sa
26/02/202417:32UK RegulatoryAB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALSLSE:0Q77Ab Science Sa
26/02/202417:32UK RegulatoryAB Science annonce que Santé Canada a émis un Avis de Non-Conformité-Retrait (ANC-R) pour le masitinib dans la SLALSE:0Q77Ab Science Sa
26/01/202417:01UK RegulatoryAB Science fait le point sur la demande d’autorisation de mise sur le marché du masitinib dans la sclérose latérale amyotrophique auprès de l’Agence Européenne des MédicamentsLSE:0Q77Ab Science Sa
26/01/202417:01UK RegulatoryAB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines AgencyLSE:0Q77Ab Science Sa
 Showing the most relevant articles for your search:LSE:0Q77

Your Recent History

LSE
WBI
Woodbois
LSE
XTR
Xtract Resources
LSE
TYM
Tertiary Minerals
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved